Xeris Biopharma Holdings, Inc. (XERS)
7.21
+0.22
(+3.15%)
USD |
NASDAQ |
Dec 09, 15:04
Xeris Biopharma Holdings Total Liabilities (Quarterly): 371.05M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Plus Therapeutics, Inc. | 13.62M |
| Assertio Holdings, Inc. | 213.97M |
| Amneal Pharmaceuticals, Inc. | 3.642B |
| NovaBay Pharmaceuticals, Inc. | 1.853M |
| Palatin Technologies, Inc. | 8.218M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 370.19M |
| Shareholders Equity (Quarterly) | -0.861M |
| Debt to Equity Ratio | -299.25 |
| Current Ratio | 1.928 |
| Net Debt Paydown Yield | 0.18% |